Literature DB >> 25762848

Hepatocellular carcinoma rupture following transarterial chemoembolization.

Nimarta Singh Bhinder1, Steven M Zangan1.   

Abstract

As the incidence of primary and metastatic liver cancer increases, minimally invasive treatment methods such as transarterial chemoembolization (TACE) have gained momentum as their efficacy and safety profile have been validated. Complications of TACE are rare and typically well tolerated. A unique complication is tumor rupture with hemorrhage. Reports of hepatocellular carcinoma (HCC) rupture after TACE are limited. It is critical to recognize this complication and understand the treatment options, which range from conservative to surgical management. This report describes a case of HCC rupture following TACE successfully managed with coil embolization.

Entities:  

Keywords:  hepatocellular carcinoma; interventional radiology; intraperitoneal hemorrhage; spontaneous rupture; transarterial chemoembolization

Year:  2015        PMID: 25762848      PMCID: PMC4346053          DOI: 10.1055/s-0034-1396964

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN: 0739-9529            Impact factor:   1.513


  29 in total

1.  Spontaneous rupture of hepatocellular carcinoma and vascular injury.

Authors:  L X Zhu; X P Geng; S T Fan
Journal:  Arch Surg       Date:  2001-06

Review 2.  Spontaneous hemoperitoneum: causes and significance.

Authors:  Brian C Lucey; Jose C Varghese; Jorge A Soto
Journal:  Curr Probl Diagn Radiol       Date:  2005 Sep-Oct

3.  A prospective, randomized, controlled trial of preoperative transarterial chemoembolization for resectable large hepatocellular carcinoma.

Authors:  Wei-Ping Zhou; Eric C H Lai; Ai-Jun Li; Si-Yuan Fu; Jian-Ping Zhou; Ze-Ya Pan; Wan Yee Lau; Meng-Chao Wu
Journal:  Ann Surg       Date:  2009-02       Impact factor: 12.969

Review 4.  Spontaneous hemoperitoneum.

Authors:  George Kasotakis
Journal:  Surg Clin North Am       Date:  2013-10-30       Impact factor: 2.741

5.  One-stage liver resection for spontaneous rupture of hepatocellular carcinoma.

Authors:  Liu Hai; Peng Yong-Hong; Fu Yong; Li Ren-Feng
Journal:  World J Surg       Date:  2005-10       Impact factor: 3.352

6.  Ultrastructural study of the vascular endothelium of patients with spontaneous rupture of hepatocellular carcinoma.

Authors:  Li-Xin Zhu; Yi Liu; Sheung-Tat Fan
Journal:  Asian J Surg       Date:  2002-04       Impact factor: 2.767

7.  Factors affecting early mortality in spontaneous rupture of hepatocellular carcinoma.

Authors:  Felicia L-S Tan; Yu-Meng Tan; Alexander Y-F Chung; Peng C Cheow; Pierce K-H Chow; London L Ooi
Journal:  ANZ J Surg       Date:  2006-06       Impact factor: 1.872

8.  Ruptured hepatocellular carcinoma following chemoembolization: a western experience.

Authors:  Narendra Battula; Parthi Srinivasan; Mansoor Madanur; Srinivas Prabhu Chava; Oliver Priest; Mohamed Rela; Nigel Heaton
Journal:  Hepatobiliary Pancreat Dis Int       Date:  2007-02

Review 9.  The various manifestations of ruptured hepatocellular carcinoma: CT imaging findings.

Authors:  Hyun Cheol Kim; Dal Mo Yang; Wook Jin; Seong Jin Park
Journal:  Abdom Imaging       Date:  2008 Nov-Dec

10.  Ruptured hepatic carcinoma after transcatheter arterial chemoembolization.

Authors:  Zhongzhi Jia; Feng Tian; Guomin Jiang
Journal:  Curr Ther Res Clin Exp       Date:  2013-06
View more
  3 in total

1.  Development of a prognostic score for recommended transarterial chemoembolization candidates with spontaneous rupture of hepatocellular carcinoma.

Authors:  Jixue Zou; Jia Yuan; Hong Chen; Xinghao Zhou; Tongchun Xue; Rongxin Chen; Lan Zhang; Zhenggang Ren
Journal:  J Gastrointest Oncol       Date:  2022-06

Review 2.  Overview of spontaneous intraabdominal tumor hemorrhage: etiologies, imaging findings, and management.

Authors:  Kevin Kalisz; Michael Enzerra; Bahar Mansoori
Journal:  Abdom Radiol (NY)       Date:  2020-07-20

3.  Rupture of Hepatocellular Carcinoma after Transarterial Chemoembolization followed by Massive Gastric Bleeding.

Authors:  Kazuhiro Nishida; Alan Kawarai Lefor; Tomohiro Funabiki
Journal:  Case Reports Hepatol       Date:  2018-06-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.